Helsinki University Hospital, Retinal Outpatient Clinic
Helsinki, Uusimaa, 00280, Finland
NCT Number: NCT05100511
The purpose of this study is to investigate the usability of fundus image-guided focal electroretinography device with healthy subjects and with macular edema and macular degeneration patients.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Helsinki, Uusimaa, 00280, Finland
In this study, we will study the usability of focal electroretinography device combined with slit lamp biomicroscope. The device allows simultaneous fundus imaging and focal ERG recording from the desired retinal area.
In phase I, the usability of the investigational device is tested with 10 healthy volunteers. The examinations include focal ERG and noise tests with commercial ERG electrodes. The stimulus lights are guided to the fundus using either non-contact of contact fundus lens. One electrode is selected for phase II based on signal-to-noise ration, usability, and comfort.
In phase II, fundus image-guided focal ERG recordings are conducted with total of 10 patients having either macular edema or macular degeneration. The aim of the phase II is to test whether the investigational device can be used to record focal ERG signal from the desired symptomatic retinal area.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Investigate the patient comfort, usability and signal-to-noise ratio of different commercial CE marked ERG electrodes.
Record focal ERG from a healthy retinal area and from an area with visible symptoms.
Time frame: Through study completion, an average of 1 year
Signal-to-noise ratio of the focal ERG signals with different ERG electrodes.
Time frame: Through study completion, an average of 1 year
Explore the device feasibility in recording focal ERG signal from areas with macular edema or macular degeneration.
Time frame: Through study completion, an average of 1 year
Investigated using a questionnaire for the subjects and investigator.
Maculaser Oy
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05538949
Eye Diseases, Healthy
Busan, South Korea
View Trial DetailsNCT00069199
Eye Diseases, Healthy
Bethesda, Maryland, United States
View Trial DetailsNCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial Details